title: A systematic review of the direct economic burden of type 2 diabetes in china.
abstract: BACKGROUND
  Type 2 diabetes is associated with acute and chronic complications and poses a large economic, social, and medical burden on patients and their families as well as society.
  
  
  OBJECTIVE
  This study aims to evaluate the direct economic burden of type 2 diabetes in China.
  
  
  METHODS
  systematic review on cost of illness, health care costs, direct service costs, drug costs, and health expenditures in relation to type 2 diabetes was conducted up to 2014 using databases such as Pubmed; EBSCO; Elsevier ScienceDirect, Web of Science; and a series of Chinese databases, including Wanfang Data, China National Knowledge Infrastructure (CNKI), and the China Science and Technology Journal Database. Factors influencing hospitalization and drug fees were also identified.
  
  
  METHODS
  (1) estimation of the direct economic burden including hospitalization and outpatient cost of type 2 diabetes patients in China; (2) evaluation of the factors influencing the direct economic burden. Articles only focusing on the cost-effectiveness analysis of diabetes drugs were excluded.
  
  
  RESULTS
  The direct economic burden of type 2 diabetes has increased over time in China, and in 2008, the direct medical cost reached $9.1 billion, Both outpatient and inpatient costs have increased. Income level, type of medical insurance, the level of hospital care, and type and number of complications are primary factors influencing diabetes related hospitalization costs. Compared to urban areas, the direct non-medical cost of type 2 diabetes in rural areas is significantly greater.
  
  
  CONCLUSIONS
  The direct economic burden of type 2 diabetes poses a significant challenge to China. To address the economic burden associated with type 2 diabetes, measures need to be taken to reduce prevalence rate and severity of diabetes and hospitalization cost.
authors: Department of Social Medicine, Center for Health Policy Studies, School of Public Health, Zhejiang Medical College, Hangzhou, China.
authors: Huimei
authors: H
authors: Hu
authors: Monika
authors: M
authors: Sawhney
authors: Lizheng
authors: L
authors: Shi
authors: Shengnan
authors: S
authors: Duan
authors: Yunxian
authors: Y
authors: Yu
authors: Zhihong
authors: Z
authors: Wu
authors: Guixing
authors: G
authors: Qiu
authors: Hengjin
authors: H
authors: Dong
references: Diabetologia. 2002 Jul;45(7):S13-7
references: 12136406
references: Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Jul;26(7):478-84
references: 16334996
references: Zhonghua Yu Fang Yi Xue Za Zhi. 2007 May;41(3):186-8
references: 17708869
references: Diabetes Care. 1994 Nov;17(11):1257-63
references: 7821164
references: N Engl J Med. 2010 Mar 25;362(12):1090-101
references: 20335585
references: Diabetes Care. 2005 Sep;28(9):2130-5
references: 16123478
references: PLoS Med. 2006 Nov;3(11):e442
references: 17132052
references: Diabetes Care. 1998 Jul;21(7):1138-45
references: 9653609
references: Di Yi Jun Yi Da Xue Xue Bao. 2002 May;22(5):472-5
references: 12390723
references: Diabet Med. 1996 Mar;13(3):273-80
references: 8689850
references: World Health Organ Tech Rep Ser. 1994;844:1-100
references: 7941615
references: Diabetes Res Clin Pract. 2011 Dec;94(3):311-21
references: 22079683
references: Diabetes Care. 1997 Nov;20(11):1664-9
references: 9353605